Login
Home / AVE.AX : ASX
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Avecho Biotechnology Limited

AUD 0.02 +$0.01 (+122.22%)
ASX · 15 Sep 2026 05:59 UTC
Previous Close
AUD 0.02
Day Range
AUD 0.02AUD 0.02
Year Range
AUD 0.01AUD 0.03
Market Cap
77.27M
AVG Volume
10.95M
Trailing/Forward PE
-13.33/-
PEG ratio
-0.07
Dividend Yield
-
Next Earnings Date
2027-03-03
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
0250K500K750K1M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (AUD)
-3M-2M-1M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (AUD)
-6M-4M-2M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (AUD)
-6M-4M-2M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (AUD)
-4M-2M02M4M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (AUD)
-0-0-0021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (AUD)
-2M02M4M6MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (AUD)
02M4M6M8MCashShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
00.250.50.75121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
-1000%-500%0%500%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
-200%-150%-100%-50%0%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
01B2B3B4B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (AUD)
00.511.5Oct 95May 97
Book Value Per Share (AUD)
000021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (AUD)
02.5M5M7.5M10M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Free Cash Flow Yield
-100%-75%-50%-25%0%med -24.26%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
010203040med 13.8Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
0204060med 19.49Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Avecho Biotechnology Limited
AVE.AX
Stockpicker

Video analysis: AVE.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AVE.AX

Positive interim analysis advances Avecho Phase III insomnia program

gurufocus.com · 29 Jun 2026

Positive interim analysis advances Avecho Phase III insomnia program

Positive interim analysis advances Avecho Phase III insomnia program PR Newswire MELBOURNE, Australia, June 29,

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.